Unlike full-length growth hormone, AOD-9604 selectively targets fat metabolism through beta-3 adrenergic receptor pathways without affecting insulin sensitivity or IGF-1 levels
Weight management medications can release the hormone without solely using food to activate L-cells by binding to the bodys GLP-1 receptors, thus successfully lowering the risk of heart disease, stroke, and kidney disease, as well as improving cholesterol and blood pressure
If you have active chronic pancreatitis, uncontrolled high triglycerides, or recurring acute episodes, your provider may recommend alternative weight loss approaches or closer monitoring protocols
DSIP doesn't appear to cause physical dependence or withdrawal symptoms
doi: 10.3389/fphar.2025.1557691 Received 09 January 2025 Accepted 19 June 2025 Published 08 July 2025 Volume 16 - 2025 Edited by David Sacerdoti, University of Verona, Italy Reviewed by Ivan oa, University of Rijeka, Croatia Filippo Cattazzo, Integrated University Hospital Verona, Italy Updates Copyright 2025 Tao, Zhang, Wan, Zhao, Chen, Wang, Yang, Wang, Ding, Shang and Zhou
[32] Thoroughbred horses were treated with omeprazole and supplemented with porcine collagen at 45 g twice per day for 56 days
